Key result
Artificial intelligence in echocardiography and CMR demonstrated high diagnostic accuracy, with deep learning algorithms achieving AUCs of 0.895 to 0.991 for cardiovascular disease classification.
Why the study?
Artificial intelligence applications in echocardiography and cardiac magnetic resonance have shown promise but face challenges in clinical adoption due to heterogeneity, limited validation, and transparency.
Does artificial intelligence improve diagnostic accuracy and workflow efficiency in echocardiography and cardiac magnetic resonance compared to conventional methods?
Does artificial intelligence improve diagnostic accuracy and workflow efficiency in echocardiography and cardiac magnetic resonance compared to conventional methods?
Answers are grounded in this paper and cite their sources.
Artificial intelligence in cardiac imaging demonstrates high diagnostic accuracy and efficiency, but widespread clinical adoption requires prospective validation and standardized protocols.
Artificial intelligence is reshaping how we image the heart. This narrative review synthesizes evidence from 22 peer reviewed studies published between 2020 and 2026, identified through PubMed, Scopus, and Web of Science, examining AI applications across echocardiography and cardiac magnetic resonance (CMR). In echocardiography, AI enables automated image acquisition, chamber and valve segmentation, and left ventricular ejection fraction measurement with accuracy matching experienced echocardiographers, while also reducing interobserver variability and analysis time. Automated global longitudinal strain analysis has further improved detection of subclinical myocardial dysfunction, abnormalities that visual assessment routinely misses. In CMR, deep learning algorithms have demonstrated strong performance in cardiac chamber segmentation, myocardial tissue characterization, and multi-class disease classification. Wang et al. reported screening and diagnostic AUCs of 0.990 and 0.991 across eleven cardiovascular disease categories, while Diao et al. achieved AUCs of 0.895-0.980 for left ventricular hypertrophy classification. Beyond single-modality gains, AI-driven risk stratification models integrating imaging with clinical data have outperformed conventional scoring tools. These advances collectively improve diagnostic accuracy, workflow efficiency, and the capacity for personalized patient management. A limitation remains real and worth acknowledging. Heterogeneity in imaging protocols, insufficient cross-population validation, and limited algorithm transparency continue to restrict widespread clinical adoption. Achieving the full potential of AI in cardiac imaging will take more than good algorithms. It will require prospective validation, equitable dataset development, clearer regulatory pathways, and genuine collaboration between clinicians, engineers, and policymakers.
No takes yet. Share an insight, caveat, or question.
Ali Hussein Choker (2026) conducted a review in Cardiovascular disease. Artificial intelligence vs. Conventional scoring tools and visual assessment was evaluated. Artificial intelligence in echocardiography and CMR demonstrated high diagnostic accuracy, with deep learning algorithms achieving AUCs of 0.895 to 0.991 for cardiovascular disease classification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: